504 related articles for article (PubMed ID: 31684144)
1. Balancing STAT Activity as a Therapeutic Strategy.
Polak KL; Chernosky NM; Smigiel JM; Tamagno I; Jackson MW
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31684144
[TBL] [Abstract][Full Text] [Related]
2. Impact of STAT Proteins in Tumor Progress and Therapy Resistance in Advanced and Metastasized Prostate Cancer.
Ebersbach C; Beier AK; Thomas C; Erb HHH
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638338
[TBL] [Abstract][Full Text] [Related]
3. STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges.
Wong GL; Manore SG; Doheny DL; Lo HW
Semin Cancer Biol; 2022 Nov; 86(Pt 3):84-106. PubMed ID: 35995341
[TBL] [Abstract][Full Text] [Related]
4. Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops.
von Manstein V; Yang CM; Richter D; Delis N; Vafaizadeh V; Groner B
Curr Signal Transduct Ther; 2013 Dec; 8(3):193-202. PubMed ID: 25045345
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in T(h)1 and T(h)2 cells.
Anderson P; Sundstedt A; Li L; O'Neill EJ; Li S; Wraith DC; Wang P
Int Immunol; 2003 Nov; 15(11):1309-17. PubMed ID: 14565929
[TBL] [Abstract][Full Text] [Related]
6. IL-6 activates STAT5 in T cells.
Tormo AJ; Letellier MC; Sharma M; Elson G; Crabé S; Gauchat JF
Cytokine; 2012 Nov; 60(2):575-82. PubMed ID: 22854263
[TBL] [Abstract][Full Text] [Related]
7. Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication.
Loh CY; Arya A; Naema AF; Wong WF; Sethi G; Looi CY
Front Oncol; 2019; 9():48. PubMed ID: 30847297
[TBL] [Abstract][Full Text] [Related]
8. STATs in cancer inflammation and immunity: a leading role for STAT3.
Yu H; Pardoll D; Jove R
Nat Rev Cancer; 2009 Nov; 9(11):798-809. PubMed ID: 19851315
[TBL] [Abstract][Full Text] [Related]
9. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.
Groner B; von Manstein V
Mol Cell Endocrinol; 2017 Aug; 451():1-14. PubMed ID: 28576744
[TBL] [Abstract][Full Text] [Related]
10. Pan-cancer analysis reveals signal transducer and activator of transcription (STAT) gene family as biomarkers for prognostic prediction and therapeutic guidance.
Cheng M; Liu Y; Guo Y; Li M; Xian S; Qin H; Yang Y; Qian W; Tang J; Lu Y; Yao Y; Zhang M; Jin M; Xu L; Huang R; Xu D
Front Genet; 2023; 14():1120500. PubMed ID: 36968603
[No Abstract] [Full Text] [Related]
11. STAT proteins as novel targets for cancer drug discovery.
Turkson J
Expert Opin Ther Targets; 2004 Oct; 8(5):409-22. PubMed ID: 15469392
[TBL] [Abstract][Full Text] [Related]
12. Cryptotanshinone suppresses key onco-proliferative and drug-resistant pathways of chronic myeloid leukemia by targeting STAT5 and STAT3 phosphorylation.
Dong B; Liang Z; Chen Z; Li B; Zheng L; Yang J; Zhou H; Qu L
Sci China Life Sci; 2018 Sep; 61(9):999-1009. PubMed ID: 30054832
[TBL] [Abstract][Full Text] [Related]
13. Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity.
Wu CJ; Sundararajan V; Sheu BC; Huang RY; Wei LH
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861720
[No Abstract] [Full Text] [Related]
14. The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development.
Clarkson RW; Boland MP; Kritikou EA; Lee JM; Freeman TC; Tiffen PG; Watson CJ
Mol Endocrinol; 2006 Mar; 20(3):675-85. PubMed ID: 16293640
[TBL] [Abstract][Full Text] [Related]
15. The STAT family: Key transcription factors mediating crosstalk between cancer stem cells and tumor immune microenvironment.
Zhu M; Li S; Cao X; Rashid K; Liu T
Semin Cancer Biol; 2023 Jan; 88():18-31. PubMed ID: 36410636
[TBL] [Abstract][Full Text] [Related]
16. Central Roles of STAT3-Mediated Signals in Onset and Development of Cancers: Tumorigenesis and Immunosurveillance.
Hashimoto S; Hashimoto A; Muromoto R; Kitai Y; Oritani K; Matsuda T
Cells; 2022 Aug; 11(16):. PubMed ID: 36010693
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
18. Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration.
Cui Y; Hosui A; Sun R; Shen K; Gavrilova O; Chen W; Cam MC; Gao B; Robinson GW; Hennighausen L
Hepatology; 2007 Aug; 46(2):504-13. PubMed ID: 17640041
[TBL] [Abstract][Full Text] [Related]
19. Human T
Zhang Y; Siegel AM; Sun G; Dimaggio T; Freeman AF; Milner JD
J Allergy Clin Immunol; 2019 Mar; 143(3):1108-1118.e4. PubMed ID: 30030006
[TBL] [Abstract][Full Text] [Related]
20. The potential and controversy of targeting STAT family members in cancer.
Verhoeven Y; Tilborghs S; Jacobs J; De Waele J; Quatannens D; Deben C; Prenen H; Pauwels P; Trinh XB; Wouters A; Smits ELJ; Lardon F; van Dam PA
Semin Cancer Biol; 2020 Feb; 60():41-56. PubMed ID: 31605750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]